{"database": "openregs", "table": "documents", "rows": [["FDA-2017-D-3101-0012", "FDA", "FDA-2017-D-3101", "ANDAs: Pre-Submission of Facility Information Related to Prioritized Generic Drug Applications (Pre-Submission Facility Correspondence) Guidance for Industry", "Other", "Guidance", "2017-11-06T04:00:00Z", 2017, 11, "2017-11-06T04:00:00Z", "2018-02-06T04:59:59Z", "2025-06-16T18:01:07Z", null, 0, 0, "0900006482c4b344"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2017-D-3101-0012"], "units": {}, "query_ms": 0.32996805384755135, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}